Genazzani A R, Sandrini G, Facchinetti F, Rizzo V, Alfonsi E, Sances G, Calvani M, Nappi G
Cephalalgia. 1986 Sep;6(3):175-9. doi: 10.1046/j.1468-2982.1986.0603175.x.
L-Tryptophan (L-TP) has been used in migraine and other pain conditions. The mechanism underlying the analgesic effect is still partly undefined. In this study the effects of subchronic administration of L-5-hydroxytryptophan (L-5HTP) (with and without carbidopa) on plasma beta-endorphin (beta-EP) levels and subjective pain threshold and tolerance were investigated in seven healthy volunteers. To measure also an objective indicator of pain, the nociceptive flexion reflex threshold was studied. L-5HTP treatment with and without carbidopa administration increased beta-EP levels significantly (p less than 0.05). L-5HTP plus carbidopa induced an increase in beta-EP significantly (p less than 0.05) greater than that induced by L-5HTP alone. Neither the subjective pain threshold and tolerance nor the RIII threshold was modified by either treatment. Our data seem to point to the existence of a complex linkage between plasma opioid levels and pain perception.
L-色氨酸(L-TP)已被用于偏头痛和其他疼痛病症。镇痛作用的潜在机制仍部分未明确。在本研究中,对7名健康志愿者研究了亚慢性给予L-5-羟色氨酸(L-5HTP)(加或不加卡比多巴)对血浆β-内啡肽(β-EP)水平以及主观疼痛阈值和耐受性的影响。为了测量疼痛的客观指标,还研究了伤害性屈曲反射阈值。给予L-5HTP加或不加卡比多巴治疗均显著提高了β-EP水平(p<0.05)。L-5HTP加卡比多巴诱导的β-EP升高显著(p<0.05)大于单独使用L-5HTP所诱导的升高。两种治疗均未改变主观疼痛阈值和耐受性以及RIII阈值。我们的数据似乎表明血浆阿片类物质水平与疼痛感知之间存在复杂的联系。